Laboratorio Raffo Report issue

For profit Phase 4
Founded: Buenos Aires Argentina (1898)
Status: No NME R&D (1898)

Organization Overview

First Clinical Trial
2012
NCT02343081
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

temozolomide (temodar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Neoplasms (Phase 4)

Central Nervous System Neoplasms (Phase 4)

Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1